Objectives: We sought to characterize the correlation between diagnoses made during telerheumatology and face-to-face visits and to document patients' satisfaction with telerheumatology visits.
T echnological advances have enabled the rapid growth of telemedicine services. [1] [2] [3] In more remote rural areas, telemedicine could offer increased access to specialty care 2 and has been explored as a solution to the shortage of rheumatology practitioners. 4 In a report from England, urban-based rheumatologists who conducted telerheumatology evaluations in conjunction with general practitioners at remote sites found good correlation between the diagnoses made at telerheumatology visits and the subsequent gold standard face-to-face visit with a rheumatologist. 4 In the United States, a shortage of primary care providers is expected with the implementation of the Patient Protection and Affordable Health Care Act (PL 111-148), and physician extenders such as nurse practitioners (NP) and physician assistants have functioned in roles previously performed by primary care physicians. 5 The US Department of Veterans Affairs (VA) Health Care System has been conducting telemedicine visits using physician extenders. This article describes the Palo Alto VA experience using telerheumatology visits for new consults, with an NP at the community clinic. The aims of this study were to describe the correlation between the diagnoses made during telerheumatology and face-to-face rheumatology visits and to describe patient satisfaction with telerheumatology visits.
Methods
This study was an institutional review board-exempted practice modification project conducted at the VA, a national healthcare system that, as of fiscal year 2015, provides care for nearly 9 million veterans. 6 The VA has conducted multiple quality assurance projects to evaluate the use of telemedicine in providing specialty care in community clinics. This project was conducted at the Palo Alto VA system, which provides outpatient rheumatology care at two campuses (Palo Alto and Livermore, California) and primary care at nine campuses (Livermore, Modesto, Stockton, Sonora, Palo Alto, Monterey, Capitola, San Jose, and Fremont, California). The majority of patients seen at the Livermore rheumatology practice was referred from VA primary care clinics in rural areas.
Clinical Information and Diagnoses
Between March 2013 and December 2014, patients referred to the Livermore rheumatology clinic (for one rheumatologist, M.L.)
• Despite equipment problems, the rheumatologist correctly classified the condition 79% of the time during telerheumatology visits.
• Patients identified as having an inflammatory or rheumatic condition were seen sooner than those classified as not having an inflammatory or a rheumatic condition (average 43 days vs 65 days, P = 0.02).
• All of the patients rated the telerheumatology visit highly (10/10), and 95% of those contacted by telephone later were willing to have another telerheumatology visit.
were offered the option of a telerheumatology appointment, and all of the patients agreed to participate. All of these participants resided in rural or semirural areas. For the telerheumatology visits, patients were seen at one of two rural primary care sites (Modesto or Stockton clinics) by a certified NP, who has worked in the rheumatology clinic with a rheumatologist (M.L.) for several years after having received her certification. A complete history and physical was taken, the assessment and plan of care was formulated, and a rheumatologist (M.L.) provided consultation from the Livermore clinic via telelink. During the telerheumatology visits, the rheumatologist could ask and answer questions, obtain a closer look at any joint over the telelink, and review the electronic medical record. The rheumatologist provided the diagnoses for these telerheumatology visits for the study. Additional workups were requested in many cases and incorporated into the subsequent face-to-face evaluations and diagnoses. The time spent by both providers was recorded.
All of the patients had a second gold standard face-to-face visit with the same rheumatologist (M.L.) at the Livermore clinic to confirm their diagnoses. 4 The rheumatologist calculated the distance each patient had traveled based on information reported by the patient. The following diagnoses were classified as inflammatory, rheumatic conditions: systemic lupus erythematosus, inflammatory spondyloarthropathy, arthritis associated with psoriasis, reactive arthritis, seronegative inflammatory polyarthropathy, crystal arthropathy, polymyalgia rheumatica, and vasculitis. Classification of the inflammatory rheumatic conditions was performed based on the American College of Rheumatology (ACR) classification criteria, whenever possible (ACR classifications were used for gout, rheumatoid arthritis, and systemic lupus erythematosus), and Assessment of SpondyloArthritis International Society criteria (for ankylosing spondylitis, psoriatic arthritis, and reactive arthritis). [7] [8] [9] [10] [11] [12] [13] Patients with early manifestation of suspected rheumatoid arthritis who did not fulfill the ACR classification criteria were classified as having inflammatory polyarthritis. Osteoarthropathy, regional syndromes (eg, rotator cuff tendonitis), bursitis, fibromyalgia, and chronic pain were classified as noninflammatory, nonrheumatic conditions.
Patient Satisfaction
Before leaving the telerheumatology visit, patients were asked to rate their satisfaction on a 10-point scale (Appendix, http://links.lww.com/SMJ/A91). After the face-to-face visits, a different rheumatologist asked the patients to rerate their satisfaction via the telephone, and the patients were asked whether they would prefer future telerheumatology versus face-to-face visits (Appendix, http://links.lww.com/SMJ/A91).
Statistical Analysis
Descriptive statistics were used to report the diagnostic correlation between the telerheumatology and face-to-face visits recorded by the rheumatologist. The Student t test was used to compare the time (in days) from the telerheumatology visit to the face-to-face visit between patients with and without an inflammatory, rheumatic condition. Satisfaction was rated from 1 to 10; however, because the majority of patients rated the visit as 10, the rating was reported as a binary variable (10 or <10). Preference for telerheumatology versus face-to-face visits was analyzed as a binary variable using the Fisher exact test. All of the analyses were performed using the SPSS statistical program (IBM SPSS Statistics, Armonk, NY).
Results

Clinical Information and Diagnoses
Initially, 39 patients were enrolled in the study. Because one died and was excluded from the study, data from 38 patients were analyzed. One patient received telerheumatology at Stockton, and the rest were seen at the Modesto clinic. The average age was 57 years, and 36 patients (92%) were men. The average time spent during the initial telerheumatology visit was 42 minutes for the rheumatologist and 72 minutes for the NP. Of note, in eight different visits, the telelink did not function properly.
After their telerheumatology visits, 23 patients were diagnosed as having an inflammatory, rheumatic condition (group 1 in the Table) . Additional laboratory tests and images were ordered before the next visit in many cases. At the face-to-face visits, 15 patients were confirmed to have inflammatory, rheumatic conditions 
Osteoarthritis (1) Arthritis with psoriasis (1)
Arthritis with psoriasis (1)
Reactive arthritis (1) Reactive arthritis (1)
Rheumatoid arthritis (3) Rheumatoid arthritis (2) Inflammatory arthritis (1)
Inflammatory arthritis (7) Inflammatory arthritis (2) Rheumatoid arthritis (1) Osteoarthritis (3) Carpal tunnel syndrome (1) PMR (3) Rotator cuff tendonopathy (1) Scapulothoracic syndrome (1) Osteoarthritis (1) Gout (3) Gout (3)
Group 2
Osteoarthritis (8) Osteoarthritis (8) Fibromyalgia (4) Fibromyalgia (4) Rotator cuff impingement (2) Rotator cuff impingement (2) Bursitis (1) Bursitis (1) Boldface type indicates confirmation of inflammatory, rheumatic condition. PMR, polymyalgia rheumatica; SLE, systemic lupus erythematosus.
(boldface type, last column, group 1 in the Table) . The other eight were subsequently diagnosed as having a noninflammatory, nonrheumatic condition at the face-to-face visit; however, the rheumatologist identified all of the patients with an inflammatory or a rheumatic condition at the telerheumatology visit. Of the 15 patients not initially diagnosed as having an inflammatory or a rheumatic condition, all were subsequently confirmed (group 2 in the Table) . The rheumatologist correctly classified the condition of 30 of 38 patients (as inflammatory, rheumatic condition in 15 of 23 patients and as noninflammatory, nonrheumatic in 15 of 15 patients); thus, the overall diagnostic correlation was 79% of the time at the telerheumatology visits, but this number likely would have been higher had the equipment functioned properly in all of the cases. Among several patients with an initial telelink malfunction, the face-to-face visit offered the first opportunity for the rheumatologist to see the patient. The average time from the telerheumatology visit to the subsequent face-to-face visit was 43 days for patients initially identified as having an inflammatory, rheumatic condition versus 65 days for those having a noninflammatory, nonrheumatic condition (P = 0.02).
Patient Satisfaction
Of the 38 patients included in the study, one had missing information on the satisfaction rating, and 37 completed the satisfaction survey. Immediately after the telehealth visit, all 37 patients rated the visits at the highest level of satisfaction (10 out of 10). At the follow-up telephone survey, 30 patients (81%) still rated their satisfaction with the telemedicine visits as 10 out of 10. During the same telephone survey, 35 patients (95%) reported that they would be willing to have a future telemedicine visit. Among patients with an inflammatory, rheumatic condition, 67% preferred a face-toface visit versus 41% of patients with a noninflammatory, nonrheumatic condition (not statistically significant). On average, patients traveled 35 miles to the telemrheumatology visit and 63 miles to the face-to-face visit.
Discussion
In more than one-third of our new consultations, a noninflammatory, nonrheumatic condition was diagnosed during the telerheumatology visit and confirmed later in all of the cases. If this finding can be replicated in a larger study, then it suggests that for those diagnosed as having a noninflammatory, nonrheumatic condition at the telerheumatology visit, a face-to-face visit could be optional. For patients with difficulty in traveling to rheumatology clinics, telerheumatology would be a valuable service. Our survey indicated that a lower percentage of these patients would prefer face-to-face visits, 41% versus 67%, but the difference was not statistically significant, likely because of the small sample size.
The overall diagnostic correlation in this study, 79%, was lower than previously reported, 4 in part because of equipment malfunction. Also, in some cases, additional workup after the telerheumatology visit provided information that clarified the diagnoses at the face-to-face visits. Inflammatory, rheumatic conditions were overdiagnosed at telerheumatology to ensure that all patients with inflammatory, rheumatic conditions were identified for early follow-up and treatment to reduce the longterm complications associated with chronic inflammation. 14, 15 Those diagnosed as having inflammatory, rheumatic conditions at the telerheumatology visits were prioritized for a face-to-face visit in this study.
In this study, telerheumatology did not save the rheumatologist time because the telerheumatology visit took close to 1 hour, similar to the usual time allotted for a new consult. We did not collect cost-effectiveness data for telerheumatology; however, significant costs were associated with the initial investment in telehealth equipment and time spent by two providers (the NP and the rheumatologist). Telerheumatology can increase access to rheumatology care for those who have problems traveling, and patients can experience cost savings. [1] [2] [3] Ultimately, making telerheumatology accessible and effective will be important for patients living in more remote, rural areas. 3 Telerheumatology was well received by patients in this study, as in previous reports. 16 Future studies of the efficacy and cost-effectiveness of telerheumatology and telehealth are needed to inform policy makers about this rapidly expanding field. [1] [2] [3] Telerheumatology follow-up for patients with a rheumatic complaint is being studied at our institution and elsewhere. 16 In addition, our preliminary data analysis suggested satisfaction with telerheumatology by the NP and rheumatologist (unpublished observation; information on providers' satisfaction was collected but analysis was not completed). Generalization of this study is limited because of the small sample size, the convenient sampling, and the population studied, mostly men from the VA, as well as the limitations associated with a retrospective study. Another limitation was our inability to directly compare the amount of time spent by providers during telerheumatology visits versus the face-to-face visits.
Conclusions
Telerheumatology at the Palo Alto VA was well received by patients; provided accurate diagnosis of noninflammatory, nonrheumatic conditions; and may be appropriate for screening and prioritizing patients for in-person rheumatology clinics.
